Neurocrine Biosciences to Host Analyst Day on December 5, 2023

Uncategorized
December 1, 2023
img: Featured

SAN DIEGO , Dec. 1, 2023 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX), a leading neuroscience-focused biopharmaceutical company, will hold its Analyst Day focused on its R&D portfolio and strategy on Tuesday, December 5, 2023 in New York .

Uncategorized